Page results
-
The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements.
-
Dr Manjit Matharu's major research interests include migraine, trigeminal autonomic cephalalgias, facial pain, neurostimulation for intractable headaches, spontaneous intracranial hypotension and other headache disorders in hypermobility syndromes.
-
Education and training videos for Red Cell Network patients
-
This booklet has been written by the Autonomic Unit at The National Hospital for Neurology and Neurosurgery (NHNN). The aim of the booklet is to provide information about the 24-hour ambulatory blood pressure and heart rate (24-hr BP) monitor.
-
This page is for patients who have been asked to take part in a service evaluation looking at Magnetic Resonance Imaging (MRI) at the Proton Beam Therapy department at UCLH. This information explains why we are doing this evaluation and what it would involve for you.
-
Patient information for Red Cell Network patients
-
A combination of two drugs could be an effective treatment for the debilitating disease lupus, according to preliminary evidence from a UCLH led trial.
-
This leaflet has written by the administration team at the National Hospital for Neurology and Neurosurgery for outpatients.
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
-
London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.
File results
-
FOI/2024/0312 - Cleaning brushes and theatre equipment in sterilisation decontamination unit
-
FOI/2024/0317 - Physician associate/ Anaesthesia associate shift hours 2010-2023
-
FOI/2024/0318 - Patients absconded from medium/ high-security psychiatric facilities
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0333 - Elective treatment wait over 65 weeks